Implementation of COVID-19 vaccination services in prison in six European countries: translating emergency intervention into routine life-course vaccination.

COVID-19 Europe Health inequities Prison Vaccination

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
10 Apr 2024
Historique:
received: 27 06 2023
accepted: 10 02 2024
medline: 11 4 2024
pubmed: 11 4 2024
entrez: 10 4 2024
Statut: epublish

Résumé

Evidence has shown that the risk of transmission of SARS-CoV-2 is much higher in prisons than in the community. The release of the COVID-19 vaccine and the recommendation by WHO to include prisons among priority settings have led to the inclusion of prisons in national COVID-19 vaccination strategies. Evidence on prison health and healthcare services provision is limited and often focuses on a single country or institution due to the multiple challenges of conducting research in prison settings. The present study was done in the framework of the EU-founded project RISE-Vac. It aimed to analyse the best practices and challenges applied in implementing COVID-19 universal vaccination services during the pandemic to support future expansion of routine life course vaccination services for people living in prison (PLP). Two online cross-sectional surveys were designed and piloted: survey1 on prison characteristics and (non-COVID-19) immunisation practices; survey2 on the implementation and coverage of COVID-19 vaccination with open-ended questions for thematic analysis. Each RISE-Vac project partner distributed the questionnaire to one or two prisons in their country. Answers were collected from eight European prisons' directors or medical directors between November 2021-May 2022. According to our findings, the implementation modalities of COVID-19 vaccination services in the surveyed prisons were effective in improving PLP vaccination coverage. Strategies for optimal management of the vaccination campaign included: periodic time slot for PLP vaccination; new staff recruitment and task shifting; distribution of informational material both to PLP and prison staff. Key challenges included continuity of care after release, immunisation information system, and vaccine hesitancy. To the best of our knowledge, this is the first study describing the implementation of COVID-19 vaccination services in European prisons, suggesting that the expansion of vaccination provision in prison is possible. There is no unique solution that will fit every country but commonalities likely to be important in the design and implementation of future vaccination campaigns targeting PLP emerged. Increased availability of vaccination services in prison is not only possible, but feasible and highly desirable, and can contribute to the reduction of health inequalities.

Sections du résumé

BACKGROUND BACKGROUND
Evidence has shown that the risk of transmission of SARS-CoV-2 is much higher in prisons than in the community. The release of the COVID-19 vaccine and the recommendation by WHO to include prisons among priority settings have led to the inclusion of prisons in national COVID-19 vaccination strategies. Evidence on prison health and healthcare services provision is limited and often focuses on a single country or institution due to the multiple challenges of conducting research in prison settings. The present study was done in the framework of the EU-founded project RISE-Vac. It aimed to analyse the best practices and challenges applied in implementing COVID-19 universal vaccination services during the pandemic to support future expansion of routine life course vaccination services for people living in prison (PLP).
METHODS METHODS
Two online cross-sectional surveys were designed and piloted: survey1 on prison characteristics and (non-COVID-19) immunisation practices; survey2 on the implementation and coverage of COVID-19 vaccination with open-ended questions for thematic analysis. Each RISE-Vac project partner distributed the questionnaire to one or two prisons in their country. Answers were collected from eight European prisons' directors or medical directors between November 2021-May 2022.
RESULTS RESULTS
According to our findings, the implementation modalities of COVID-19 vaccination services in the surveyed prisons were effective in improving PLP vaccination coverage. Strategies for optimal management of the vaccination campaign included: periodic time slot for PLP vaccination; new staff recruitment and task shifting; distribution of informational material both to PLP and prison staff. Key challenges included continuity of care after release, immunisation information system, and vaccine hesitancy.
CONCLUSIONS CONCLUSIONS
To the best of our knowledge, this is the first study describing the implementation of COVID-19 vaccination services in European prisons, suggesting that the expansion of vaccination provision in prison is possible. There is no unique solution that will fit every country but commonalities likely to be important in the design and implementation of future vaccination campaigns targeting PLP emerged. Increased availability of vaccination services in prison is not only possible, but feasible and highly desirable, and can contribute to the reduction of health inequalities.

Identifiants

pubmed: 38600540
doi: 10.1186/s12889-024-18063-2
pii: 10.1186/s12889-024-18063-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1001

Subventions

Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353
Organisme : Third Health Programme
ID : 101018353

Informations de copyright

© 2024. The Author(s).

Références

Aebi MF, Tiago MM. Prison Population SPACE I– 2020. 2021.
European Monitoring Centre for Drugs and Drug Addiction. Prison and drugs in Europe: current and future challenges. Publ Off Eur Union, Luxemb [Internet]. 2022; Available from: https://www.emcdda.europa.eu/system/files/publications/13904/TDXD21001ENN.pdf .
World Health Organisation. 6th Prison Health Conference Prison health systems: the interface with wider national health systems. 2019. https://apps.who.int/iris/bitstream/handle/10665/347071/WHO-EURO-2019-3714-43473-61068
Gaskin GL, Glanz JM, Binswanger IA, Anoshiravani A. Immunization Coverage Among Juvenile Justice Detainees. J Correct Heal Care [Internet]. 2015;21(3):265–75. https://doi.org/10.1177/0885066615587790 .
Winkelman TNA, Dasrath KC, Young JT, Kinner SA. Universal health coverage and incarceration. Lancet Public Heal [Internet]. 2022;7(6):e569–72. https://doi.org/10.1016/S2468-2667(22)00113-X .
Vicente-Alcalde N, Ruescas-Escolano E, Harboe ZB, Tuells J. Vaccination coverage among prisoners: a systematic review. Int J Environ Res Public Health. 2020 Oct 19;17(20):7589. https://doi.org/10.3390/ijerph17207589 . PMID: 33086513; PMCID: PMC7589151.
Madeddu G, Vroling H, Oordt-Speets A, Babudieri S, O’Moore É, Noordegraaf MV et al. Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries. Vaccine [Internet]. 2019;37(35):4906–19. https://doi.org/10.1016/j.vaccine.2019.07.014 .
Nakitanda AO, Montanari L, Tavoschi L, Mozalevskis A, Duffell E. Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis. Epidemiol Infect. 2021 Jan 25;149:e59. https://doi.org/10.1017/S0950268821000169 . PMID: 33487201; PMCID: PMC8060813.
World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC). Good governance for prison health in the 21st century. A policy brief on the organization of prison health [Internet]. 2013. Available from: https://www.euro.who.int/__data/assets/pdf_file/0017/231506/Good-governance-for-prison-health-in-the-21st-century.pdf .
WHO COVID- Status report on prison health in the WHO European Region. Copenhagen WHO Reg Off Eur [Internet]. 2023; Available from: https://www.who.int/europe/publications/i/item/9789289058674 .
Neufeld M, Alves da Costa F, Ferreira-Borges C. Prisons need to be included in global and national vaccinations effort against COVID-19. Lancet Reg Heal - Eur [Internet]. 2021;4:100088. https://doi.org/10.1016/j.lanepe.2021.100088 .
Mazzilli S, Tavoschi L, Soria A, Fornili M, Cocca G, Sebastiani T, et al. COVID-19 infection among incarcerated individuals and prison staff in Lombardy, Italy, March 2020 to February 2021. JAMA Netw Open. 2022;5(March 2020):1–13.
Why people living and working in detention facilities should be included in national COVID-19 vaccination plans. Copenhagen WHO Reg Off Eur [Internet]. 2021;1–14. Available from: https://www.who.int/europe/publications/i/item/WHO-EURO-2021-2569-42325-58577 .
Health in Prisons. – COVID-19 Minimum Dataset: Summary of data reported from May 2020 to October 2021. Copenhagen WHO Reg Off Eur. 2022;(October).
Ismail N, Tavoschi L, Moazen B, Roselló A, Plugge E. COVID-19 vaccine for people who live and work in prisons worldwide: a scoping review. PLoS ONE. 2022;17(9 September):1–19.
European Centre for Disease Prevention and Control, World Health Organization. Joint ECDC-WHO Regional Office for Europe Weekly COVID-19 Surveillance Bulletin [Internet]. 2022 [cited 2022 Dec 21]. Available from: https://worldhealthorg.shinyapps.io/euro-covid19/ .
Our World in Data. Coronavirus (COVID-19) Vaccinations [Internet]. 2022 [cited 2022 Dec 21]. Available from: https://ourworldindata.org/covid-vaccinations .
Biswas N, Mustapha T, Khubchandani J, Price JH. The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers. J Community Health [Internet]. 2021;46(6):1244–51. https://doi.org/10.1007/s10900-021-00984-3 .
Casey RM, Adrien N, Badiane O, Diallo A, Loko Roka J, Brennan T et al. National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned. Vaccine [Internet]. 2022;40:A10–6. https://doi.org/10.1016/j.vaccine.2021.08.042 .
Bennett C, Perry J, Lapworth T, Davies J, Preece V. Supporting prison nurses: an action research approach to education. Br J Nurs. 2010;19(12):782–7.
doi: 10.12968/bjon.2010.19.12.48657 pubmed: 20622798
Perry AE, Waterman MG, House AO, Greenhalgh J. Implementation of a problem-solving training initiative to reduce self-harm in prisons: a qualitative perspective of prison staff, field researchers and prisoners at risk of self-harm. Heal Justice. 2019;7(1).
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach—second edition. Vol. 5. 2016.
Oru E, Trickey A, Shirali R, Kanters S, Easterbrook P. Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis. Lancet Glob Heal [Internet]. 2021;9(4):e431–45. https://doi.org/10.1016/S2214-109X(20)30505-2 .
Allison M, Emerson A, Pickett ML, Ramaswamy M. Incarcerated adolescents’ attitudes toward Human Papillomavirus Vaccine: Report from a Juvenile Facility in Kansas. Glob Pediatr Heal. 2019;6.
Junghans C, Heffernan C, Valli A, Gibson K. Mass vaccination response to a measles outbreak is not always possible. Lessons from a London prison. Epidemiol Infect. 2018;146(13):1689–91.
doi: 10.1017/S0950268818001991 pubmed: 30021664 pmcid: 9507953
World Health Organization. Organizational models of prison health. Considerations for better governance. 2020 Available from: https://apps.who.int/iris/bitstream/handle/10665/336214/WHO-EURO-2020-1268-41018-55685-eng .pdf?sequence=1&isAllowed=y.
Morris NP, Zisman-Ilani Y. Communication over incarceration: improving Care Coordination between Correctional and Community Mental Health Services. Psychiatr Serv. 2022;73(12):1409–11.
doi: 10.1176/appi.ps.202200041 pubmed: 35652192
United Nations Office on Drugs and Crime (UNODC), World Health Organization. Regional Office for Europe. Good governance for prison health in the 21st century. A policy brief on the organization of prison health. 2013. Available from: https://apps.who.int/iris/bitstream/handle/10665/326388/9789289000505-eng.pdf?sequence=1&isAllowed=y
Palmateer NE, Goldberg DJ, Munro A, Taylor A, Yeung A, Wallace LA, et al. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs. Addiction. 2018;113(1):80–90.
doi: 10.1111/add.13944 pubmed: 28710874
World Health Organization (WHO). Immunization Agenda 2030: A Global Strategy to Leave No One Behind. 2020;(August):1–24. Available from: https://www.who.int/immunization/ia2030_Draft_One_English.pdf?ua=1 .
European Commission, EUROPE’S BEATING, CANCER PLAN Communication from the commission to the European Parliament and the Council. 2021; Available from: https://health.ec.europa.eu/system/files/2022-02/eu_cancer-plan_en_0.pdf .
United Nations (UN). The Sustainable Development Goals. [Internet]. New York: UN. Available from: https://sdgs.un.org/goals .
Cairo, WHO Regional Office for the Eastern Mediterranean. Consultation on integrated management of HIV, hepatitis, TB and STIs for key populations. 2019;(June 2019). Available from: https://www.who.int/europe/publications/i/item/9789289058674 .
UNODC. United Nations Standard Minimum Rules for the Treatment. Unodc [Internet]. 2015;16487(September):1–36. Available from: https://www.unodc.org/documents/justice-and-prison-reform/Nelson_Mandela_Rules-E-ebook.pdf .

Auteurs

Sara Mazzilli (S)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Scuola Normale Superiore, Pisa, Italy.

Nicola Cocco (N)

Infectious Diseases Service, Penitentiary Health System, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo, Milan, Italy.

Davide Petri (D)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Babak Moazen (B)

Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt/Main, Germany.
Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Federal Republic of Germany.

Alicia Rosello (A)

UK Health Security Agency, London, UK.

Jemima D'Arcy (J)

UK Health Security Agency, London, UK.

Emma Plugge (E)

Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.

Laura Baglietto (L)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Eva Murauer (E)

Health Unit of the Villeneuve-les-Maguelone prison, University Hospital Centre Montpellier, Montpellier, France.

Heino Stöver (H)

Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt/Main, Germany.

Tassos Trattonikolas (T)

Ministry of Justice and Public Order - Cyprus Prison Department, Nicosia, Cyprus.

Iakovos Stylianou (I)

Ministry of Justice and Public Order - Cyprus Prison Department, Nicosia, Cyprus.

Svetlana Doltu (S)

Act For Involvement, Chișinău, Republic of Moldova.

Vladislav Busmachiu (V)

National Administration of Penitentiaries, Chișinău, Republic of Moldova.

Josefina Mavrou (J)

Cyprus National Addictions Authority, Nicosia, Cyprus.

Ioanna Yiasemi (I)

Cyprus National Addictions Authority, Nicosia, Cyprus.

Irina Barbiros (I)

National Administration of Penitentiaries, Chișinău, Republic of Moldova.

Filipa Alves da Costa (FA)

Health in Prisons Programme, WHO Regional Office for Europe, Copenhagen, Denmark.

Fadi Meroueh (F)

Health Unit of the Villeneuve-les-Maguelone prison, University Hospital Centre Montpellier, Montpellier, France.

Roberto Ranieri (R)

Infectious Diseases Service, Penitentiary Health System, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo, Milan, Italy.

Lara Tavoschi (L)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. lara.tavoschi@unipi.it.

Classifications MeSH